Approval · Notice of Compliance 28902 · 2022
OPSUMIT: Notice of Compliance 28902
Issued September 6, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28902
- Date
- September 6, 2022
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To update the Product Monograph (PM) with safety information.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OPSUMIT | Not yet assigned | — |
Medicinal ingredients
- MACITENTAN 10 MG per TAB